BRAF and thyroid gland carcinoma: Alterations in the MAPK [MAPK kinase (MEK)/ERK] signaling pathway, such as mutant BRAF, RAS, and RET fusions represent the majority of alterations in differentiated thyroid cancers and are key drivers in the progression of disease [9].